ACTA1 and breast carcinoma: Compared with control cells, OC-treated breast cancer cells showed reduced levels of epithelial markers (E-cadherin) and increased levels of mesenchymal markers (vimentin, N-cadherin, α-SMA, Snail and Twist) (Fig. 3c, d).